Company news
Aethlon Medical, Inc. (NASDAQ:AEMD) news
Every Aethlon Medical, Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
August 13, 2026
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 13, 2026
August 5, 2026
Aethlon Medical : Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
July 13, 2026
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
July 13, 2026
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
July 6, 2026
Aethlon Medical : Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
June 26, 2026
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
June 26, 2026
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
June 10, 2026
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
June 2, 2026
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
May 21, 2026
Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
March 24, 2026
OTC Markets Hosts Virtual Investor Presentation with Jim Frakes, CEO and CFO of Aethlon Medical, and M. Marin, Senior Analyst at Zacks SCR
March 18, 2026
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
March 12, 2026
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
Aethlon Medical to Present at the Life Sciences Investor Forum on March 12th
March 6, 2026
Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
February 24, 2026
Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026
February 23, 2026
Aethlon Medical Announces Fiscal Q3 2026 Financial Results and Corporate Update
February 12, 2026
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026
February 4, 2026
Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3....
December 5, 2025
Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular...
December 2, 2025
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
November 12, 2025
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025
November 7, 2025
Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncolo...
October 7, 2025
Aethlon Medical Announces Pricing of $4.5 Million Public Offering
September 4, 2025
Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)
September 3, 2025
Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update
August 13, 2025
Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025
August 5, 2025
Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort
July 15, 2025
Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update
June 26, 2025
Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025
June 20, 2025
Aethlon Medical Treats Second Patient in Australian Hemopurifier(R) Cancer Trial
June 19, 2025
Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial
June 18, 2025
Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream
June 16, 2025
Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes
June 9, 2025
Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular V...
May 14, 2025
Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal
March 10, 2025
Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025
February 13, 2025
Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update
February 12, 2025
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025
February 5, 2025
Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial
January 29, 2025
Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu
December 20, 2024
Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update
November 13, 2024
Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia
November 11, 2024
Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024
November 6, 2024
Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
Aethlon Receives Ethics Committee Approval for Hemopurifier® Cancer Trial in India
September 19, 2024
Aethlon Medical to Present at Virtual Investor Conferences in September
September 17, 2024
Aethlon Medical Announces Activation of Royal Adelaide Hospital to Begin Patient Screening and Enrollment in Hemopurifier® Cancer Trial
September 16, 2024